Literature DB >> 28455470

Functional outcome of debridement, antibiotics and implant retention in periprosthetic joint infection involving the hip: a case-control study.

G Grammatopoulos1, M-E Bolduc1, B L Atkins1, B J L Kendrick1, P McLardy-Smith1, D W Murray1, R Gundle1, A H Taylor1.   

Abstract

AIMS: Advocates of debridement, antibiotics and implant retention (DAIR) in hip periprosthetic joint infection (PJI) argue that a procedure not disturbing a sound prosthesis-bone interface is likely to lead to better survival and functional outcome compared with revision. This case-control study aims were to compare outcome of DAIRs for infected primary total hip arthroplasty (THA) with outcomes following primary THA and two-stage revision of infected primary THAs. PATIENTS AND METHODS: We retrospectively reviewed all DAIRs, performed for confirmed infected primary hip arthropasty (n = 82) at out institution, between 1997 and 2013. Data recorded included full patient information and type of surgery. Outcome measures included complications, mortality, implant survivorship and functional outcome. Outcome was compared with two control groups matched for gender and age; a cohort of primary THAs (n = 120) and a cohort of two-stage revisions for infection (n = 66).
RESULTS: Mean age at DAIR was 69 years (33 to 87) and mean follow-up was eight years (2 to 17; standard deviation (sd) 5). A total of 52 (63%) of DAIRs were for early PJI (less than six weeks). Greater success in the eradication of infection with DAIR was identified with early PJI, comprising an interval less than a week between onset of symptoms and exchange of modular components with the DAIR procedure. Eradication of infection, complications and re-operation rates were similar in the DAIR and two-stage revision groups. For hips with successful eradication of infection with DAIR, the five-year survival (98%; 95% confidence interval (CI) 94 to 100) was similar to the primary THA group (98%; 95% CI 95 to 100) (n = 43; p = 0.3). The DAIR group had inferior mean Oxford Hip Scores (OHS) (38; 12 to 48) compared with the primary THA group (42; 15 to 48) (p = 0.02) but a significantly better mean OHS compared with the two-stage revision group (31; 0 to 48) (p = 0.008). Patients who required only one DAIR for eradication of infection had a similar mean OHS (41; 20 to 48) to the primary THA group (p = 0.2).
CONCLUSION: The DAIR procedure is associated with a similar complication rate and ability to eradicate infection as two-stage revision. This study emphasises the need for exchange of modular components for improved chances of eradication of infection. This is the first study showing that DAIR is better than a two-stage revision regarding functional outcome. Cite this article: Bone Joint J 2017;99-B:614-22. ©2017 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Debridement, antibiotics and implant retention; Hip arthroplasty; Periprosthetic joint infection

Mesh:

Substances:

Year:  2017        PMID: 28455470     DOI: 10.1302/0301-620X.99B5.BJJ-2016-0562.R2

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  21 in total

1.  E7 peptide-functionalized Ti6Al4V alloy for BMSC enrichment in bone tissue engineering.

Authors:  Zhentao Man; Tao Li; Laibo Zhang; Lin Yuan; Changshun Wu; Ping Li; Shui Sun; Wei Li
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

2.  CORR Insights®: Late Reinfection May Recur More Than 5 Years After Reimplantation of THA and TKA: Analysis of Pathogen Factors.

Authors:  José Cordero-Ampuero
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

3.  In Vitro Study of the Synergistic Effect of an Enzyme Cocktail and Antibiotics against Biofilms in a Prosthetic Joint Infection Model.

Authors:  Hervé Poilvache; Albert Ruiz-Sorribas; Olivier Cornu; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

4.  Outcomes of Debridement, Antibiotics and Implant Retention (DAIR) for Periprosthetic Joint Infection in a High-Volume Arthroplasty Centre.

Authors:  Sriganesh Walkay; David Tran Wallace; Vijay Shankar Coimbatore Balasubramaniam; Rohit Maheshwari; Manish Changulani; Martin Sarungi
Journal:  Indian J Orthop       Date:  2022-05-28       Impact factor: 1.033

Review 5.  Indications and Guidelines for Debridement and Implant Retention for Periprosthetic Hip and Knee Infection.

Authors:  Douglas A Zaruta; Bowen Qiu; Andrew Y Liu; Benjamin F Ricciardi
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

6.  Induction heating for eradicating Staphylococcus epidermidis from biofilm.

Authors:  Bart G Pijls; Ingrid M J G Sanders; Ed J Kujiper; Rob G H H Nelissen
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

Review 7.  Periprosthetic joint infection: current concepts and outlook.

Authors:  Petra Izakovicova; Olivier Borens; Andrej Trampuz
Journal:  EFORT Open Rev       Date:  2019-07-29

8.  Periprosthetic hip infections in a Swedish regional hospital between 2012 and 2018: is there a relationship between Cutibacterium acnes infections and uncemented prostheses?

Authors:  Urban Hedlundh; Michail Zacharatos; Jonas Magnusson; Magnus Gottlander; Johanna Karlsson
Journal:  J Bone Jt Infect       Date:  2021-06-04

9.  Adherence to a reliable PJI diagnostic protocol minimizes unsuspected positive cultures rate.

Authors:  Daniel Pérez-Prieto; Pedro Hinarejos; Albert Alier; Lluïsa Sorlí; Santos Martínez; Lluís Puig; Juan C Monllau
Journal:  BMC Musculoskelet Disord       Date:  2021-08-02       Impact factor: 2.362

Review 10.  Treatment of Prosthetic Joint Infection with Debridement, Antibiotics and Irrigation with Implant Retention - a Narrative Review.

Authors:  Ricardo Sousa; Miguel Araújo Abreu
Journal:  J Bone Jt Infect       Date:  2018-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.